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increases the risk of adverse events (AEs). As health care continues to shift toward rewarding value rather than volume, it will be increasingly important to deliver care that is effective and efficient. 2 Thus, understanding factors associated with unsuccessful interventions, such as a failed ERCP, will be of critical importance to payers and patients.
Based on population-based studies, it is clear that the success rate of ERCP varies markedly between providers. 3 In most complex procedures, there is a relationship between procedure volume and outcomes, [4] [5] [6] [7] but the association between ERCP volume and outcomes (cannulation and overall success) is unclear. Thus, in part owing to a lack of data, there are no guidelines that recommend specific minimum physician or center ERCP volumes required to maintain ERCP privileges. Furthermore, although there have been numerous advances to mitigate AE risk, most notably in the reduction of post-ERCP pancreatitis, 8, 9 there are few data on the relationship of provider/center factors and AE development. Specifically, it is unclear whether higher provider and/or center ERCP volumes are associated with a reduced AE risk. Thus, although select studies have shown a clear increase in overall procedure success with increasing volume, 10 other studies have not confirmed this relationship. 11 Therefore, the goal of this study was to conduct a systematic review and meta-analysis assessing the relationship between endoscopist and center ERCP volume with ERCP success and AE rates.
Methods
We used the Preferred Reporting Items for Systematic reviews and Meta-Analyses (PRISMA) guidelines for our study. 12 The primary aim of this study was to assess the procedure success rates and adverse outcomes as compared between HV center/endoscopists and LV centers/endoscopists. A study was included in this analysis if it met the following requirements: (1) was a clinical trial, prospective study, or retrospective study; (2) was published in a peer-reviewed journal or as an abstract presented at a national meeting over the past 4 years (2013-2017); (3) provided success rates and/or AE rates after ERCP; and (4) outcomes were stratified by endoscopist and/or center volume (low vs high). Exclusion criteria included the following: (1) studies that did not stratify outcomes by total ERCP volume (eg, used sphincterotomy volume); (2) studies that included only outcomes in LV or HV centers/endoscopists, precluding comparison of outcomes based on volume; and (3) duplicate cohorts. Duplicate cohorts were identified when 2 studies used the same data source for overlapping time periods and reported the same outcome measure.
Search Strategy and Data Extraction
A search strategy was developed by the study team with the help of an expert librarian (LCO). A comprehensive search of MEDLINE, EMBASE, and the Cochrane Central Register of Controlled Trials was conducted (inception to January 2017). Detailed search terms used for each of the databases are listed in Supplementary Table 1. All citations then were exported into EndNote (Thomson Reuters, Philadelphia, PA) and all duplicates were removed. Citations then were reviewed in EndNote by 2 independent reviewers (R.N.K., S.W.). Differences were resolved by consensus. Once the final list of studies was identified, data were extracted by 2 independent reviewers into an Excel spreadsheet (Microsoft Corporation, Redmond, WA). Review articles and references from included articles also were assessed carefully to identify missed studies.
Outcomes Assessed
The primary outcome of interest was the assessment of overall procedure success rates based on endoscopist and center volume. Procedure success was defined as the completion of all intended therapeutics during ERCP or, if not reported, successful cannulation of the duct of interest. The secondary outcomes included post-ERCP AEs in HV centers and endoscopists compared with LV centers and endoscopists. The AEs assessed a priori included post-ERCP pancreatitis, bleeding, cholangitis, cardiopulmonary complications, bowel perforation, need for emergency readmission or hospitalization, early repeat ERCP, increasing length of stay, and death. The analysis on AEs focused on the assessment of overall AE rate (composite rate of all AEs) based on endoscopist and center volume. In a subset analysis, the odds ratio (OR) of post-ERCP pancreatitis based on endoscopist and center volume was calculated.
Statistical Analysis
Outcomes were reported using the OR of cannulation and overall procedure success in HV centers and HV endoscopists compared with LV centers and LV endoscopists. The standard Forrest plots were used to report individual and pooled effect estimates, with 95% confidence intervals (CIs), and to assess response consistency. Pooled-effect estimates were calculated only if there was a minimum of 3 studies that addressed a relevant end point. Heterogeneity was assessed using the I 2 and Q statistics, where a P value less than .1 for the Q statistic or an I 2 greater than 50% were used to define significant heterogeneity. When significant heterogeneity was detected, the random-effects model was used. Otherwise, fixed-effects models were used in this analysis. Studies were weighted based on the sample size. Funnel plots were used to assess and report possible publication bias for each of the outcomes. The classic fail-safe test was used to quantify this risk numerically to report the number of unpublished studies that would be required to negate the findings. Study quality was assessed using the Newcastle-Ottawa quality-assessment scale. All differences were resolved by consensus. 13 Comprehensive Meta Analysis (V3; Biostat, Inc, Englewood, NJ) was used for all statistical analyses.
A priori sources of heterogeneity were proposed and included the following: (1) variation in definitions of low and high volumes, (2) variation in definitions of success and AE outcomes across studies, (3) variation in the use of pancreatic duct stents and rectal indomethacin to prevent post-ERCP pancreatitis across studies, and (4) variation in expertise across studies and geographic locations.
Results
From the initial search of 1264 citations, 1221 were excluded based on title and abstract review, leaving 43 potentially relevant articles in which the full text was reviewed. Of these, 30 were excluded for the reasons outlined in the PRISMA diagram (Supplementary Figure 1) . Specifically, 13 were excluded because the article contained insufficient raw data, 9 were excluded because the incorrect outcome was measured (eg, radiation dose as it relates to endoscopist volume), 7 were excluded because of study design (eg, reported LV center outcomes but did not compare with HV center), and 1 was excluded because it was an editorial. Thus, after a review of the full text by 2 investigators, a total of 13 studies were included in the final analysis, totaling 59,437 procedures/patients (Supplementary Figure 1) . All included studies were published as full articles. In total, 9 included studies were prospective multicenter observational studies [14] [15] [16] [17] [18] [19] [20] [21] [22] and 2 studies were based on administrative data sets 10, 23 ; the remaining 2 studies 24, 25 were single-center retrospective studies. Details of studies included in the primary analyses are highlighted in Table 1 . Overall, the vast majority of the included studies were of sufficient quality for analysis (9 studies had a total quality score of at least 4 stars) (Supplementary Table 2 ). The threshold for defining low annual endoscopist volume varied, based on investigators' definitions, in the included studies (ranging from <25 to <156 annual ERCPs). 10, 14, 15, 17, 24, 25 Similarly, the threshold for defining low center volume in the included studies ranged from 87 to 200 annual ERCPs per center. 15, 16, [18] [19] [20] 23 Intermediatevolume cohorts, defined in select studies, were not included in this analysis because the primary aim of this study was to compare outcomes between HV and LV endoscopist/centers and, in addition, intermediate-volume cohorts were described in a limited number of studies.
Primary Outcome: Endoscopic Retrograde Cholangiopancreatography Success Rates
Based on endoscopist volume. Four studies assessed ERCP success rates based on endoscopist volume. 10, 14, 15, 22 Excluding intermediate volume endoscopists, this totaled 22,342 procedures; 11,826 procedures were in the HV group and 10,516 procedures were in the LV group. For this analysis, the I 2 was 82%, and the Q statistic was 17, both indicating significant heterogeneity. Thus, on random-effect models, the OR for success in the HV group compared with the LV group was 1.6 (95% CI, 1.2-2.1; P ¼ .001) ( Figure 1A ). The direction of the estimate was consistent in all 4 studies. This analysis showed that the odds of success were 60% higher in the HV endoscopists compared with the LV endoscopists. A funnel plot to assess for publication bias for this analysis showed minor asymmetry ( Figure 1B) . The classic fail-safe test showed that 80 null studies would be needed to change the results of this analysis. An a priori assessment of potential factors associated with heterogeneity was not performed because of the limited number of studies.
Based on center volume. Three studies 15, 16, 23 (n ¼ 15,083 procedures total; 8944 procedures in the HV group and 6139 procedures for the LV group) assessed ERCP success rates with regard to center volume. There was no significant heterogeneity (I 2 ¼ 5.5%; Q ¼ 2.1). In fixed-effects models, the OR of success in HV centers compared with LV centers was 2.0 (95% CI, 1.6-2.5; P < .0001) (Figure 2A ). This indicates that the odds of success in HV centers were double the odds of success in LV centers. Again, the direction of all 3 estimates was similar. A full plot showed no significant risk of publication bias ( Figure 2B ). The classic fail-safe test showed that 24 studies would be needed to change the results of our findings.
Secondary Outcomes: Endoscopic Retrograde Cholangiopancreatography-Related Adverse Event Outcomes
Based on endoscopist volume: composite adverse event rates. Five studies assessed the overall adverse outcomes by endoscopist volume. This totaled 7868 procedures (5375 procedures for the HV group and 2493 procedures for the LV group). For this analysis, the I 2 was 38%, and the Q statistic was 6, indicating a low level of heterogeneity. In random-effect models the OR of adverse outcomes in the HV group compared with the LV group was 0.7 (95% CI, 0.5-0.8; P ¼ .001) ( Figure 3A) . The direction of the estimate was consistent in all 5 studies. This analysis shows that the odds of having adverse outcomes were 31% lower for the HV endoscopists compared with the LV endoscopists. The funnel plot showed a low risk of publication bias ( Figure 3B ). The classic fail-safe test showed that 29 null studies would be needed to change the results of this analysis.
Based on endoscopist volume: post-endoscopic retrograde cholangiopancreatography pancreatitis. Only 3 studies looked at pancreatitis specifically as an adverse outcome based on endoscopist volume. 17, 21, 22 The total was 8289 procedures (6007 procedures for the HV group and 2282 procedures for the LV group). In this analysis, there was no statistically significant difference between HV and LV endoscopists (OR, 0.98; 95% CI, 0.50-1.91; P ¼ .046; I 2 83; Q ¼ 12) (Appendix 1). In addition, no study assessed the association between endoscopist volume and rates of post-ERCP pancreatitis stratified by severity.
Based on center volume: composite adverse event rates. Four studies 15, [18] [19] [20] assessed the overall AE rates by center volume. The total was 11,674 procedures (5740 procedures for the HV group and 5934 procedures for the LV group). For this analysis, the I 2 was 93%, and the Q statistic was 46, indicating significant heterogeneity. In random-effect models the OR of adverse outcomes in the HV centers compared with the LV centers was 0.72 (95% CI, 0.34-1.52; P ¼ .39) ( Figure 3C ). This shows no significant difference in overall adverse outcomes between HV and LV centers.
Based on center volume: post-endoscopic retrograde cholangiopancreatography pancreatitis and mortality. There were 4 studies including 13,501 procedures (7733 procedures in the HV group and 5768 procedures in the LV group) that assessed the overall risk of post-ERCP pancreatitis. [18] [19] [20] [21] There was no significant difference in the risk of post-ERCP pancreatitis between HV and LV centers (OR, 1.16; 95% CI, 0.79-1.84; P ¼ .542; I 2 ¼ 75%; Q ¼ 12) (Appendix 2). Similarly, there was no significant difference in the risk of mortality between HV and LV centers (OR, 0.68; 95% CI, 0.39-1.18; P ¼ .173; I 2 ¼ 79%; Q ¼ 14) (Appendix 3).
Discussion
Procedure volume often serves as a proxy for proficiency and clinical outcomes, at least for complex procedures. 26 The increasing complexity and risk of AEs associated with ERCP coupled with a lack of clear understanding regarding the association between ERCP and clinical outcomes provided the impetus for the current study. The results of this systematic review and metaanalysis showed a significant relationship between increasing endoscopist (OR, 1.6; 95% CI, 1.2-2.1) and center (OR, 2; 95% CI, 1.6-2.5) ERCP volume with overall procedure success. Furthermore, increasing endoscopist volume also was associated with a decreased AE rate (OR, 0.7; 95% CI, 0.5-0.8). Together, these data highlight important variations, correlating with procedure volume, in ERCP quality and safety in this era of value-based and quality-based health care. The clinical importance of such variation also highlights the potential role of regionalizing complex endoscopic care to higher-volume endoscopists and centers of expertise.
Within the realm of surgery, there has been a compelling push to regionalize complex surgery to high-volume surgeons and centers. This has been driven largely by studies showing wide variation in riskadjusted patient mortality across surgeons. 27, 28 For example, in 2015, leaders at 3 major US academic medical centers took a pledge to prevent certain surgeries, such as pancreas cancer resections, from being performed by low-volume surgeons/hospitals. 29 However, despite decades of compelling data that equate surgical volume with outcomes including mortality and process measures, there has been significant resistance to regionalizing surgical care. 4, 5, 30 Similarly, there are multiple reasons to resist regionalizing endoscopic procedures; of particular importance, although low-volume surgeons may be associated with worse outcomes, low volume is not specifically the cause of poor outcomes. In other words, there clearly will be low-volume endoscopists/centers with good outcomes and, similarly, high-volume endoscopists/centers with poor outcomes. Multiple other endoscopist factors such as experience (years in practice), composition of training, complexity of case mix, and patient factors, influence ERCP outcomes. 31 Furthermore, it is impractical to regionalize all endoscopic care because some patients may be unwilling or unable to travel for care.
Although these results confirm a significant relationship between increasing endoscopic and center volume and success, the results of this study also highlight the potential variable definitions of ERCP success. Numerous definitions of success have been proposed in the literature, but most definitions are used because of ease of data abstraction rather than representing more comprehensive end points. Several studies used the need for percutaneous biliary drainage or an early repeat ERCP as definitions of failure. Other studies considered cannulation of the duct of interest as a surrogate for procedure success. However, the most useful definition for success is the hardest to measure in administrative data sets and requires a robust quality registryspecifically, a successful ERCP is one in which all intended therapeutics occurred. As we move toward measuring ERCP success, we should ensure that this outcome, which is of central importance to the patient, is tracked among other relevant quality indicators in ERCP. 32 Future work also should focus on addressing the challenges of measurement and evaluation such as the creation of national data repositories and linking them to public reporting.
Although procedure success is a critically important outcome of ERCP, minimizing AE rates is of equivalent importance. The relationship between volume and AEs was mixed in this study. Although increasing endoscopist volume was associated with low AE rates, this was not seen for center volume. Furthermore, we found no relationship between either endoscopist or center volume and rate of pancreatitis. There are several potential reasons for these findings. Although it is tempting to attribute the lack of association of volume and select AEs to unmeasured differences in procedure complexity, this is a conjecture until higher-quality studies are available. In contrast, there may be no significant relationship between endoscopist/center volume and pancreatitis. Instead, patient factors may dominate pancreatitis risk. Alternatively, with regard to center volume and AE rates, it is possible that HV centers are composed of 1 or more LV endoscopists. The conflicting data-that HV endoscopists, but not HV centers, have lower AE ratesrequires further study.
The results of this study should be considered in light of several limitations, particularly those related to the variable definitions of success and volume. The minimum thresholds required for an endoscopist and center to maintain ERCP skills and optimal clinical outcomes have not been defined. It is intuitive that there is no critical volume threshold wherein outcomes suddenly improve. Nevertheless, the minimum annual endoscopist case volume and center case volume defined in this analysis defined as low volume was <25 and <87, respectively. However, these volumes varied widely between studies, highlighting the variability in low-/high-volume definitions. In addition, the relative importance of endoscopist vs center volume remains unclear; in other words, it is unknown whether LV endoscopists can achieve optimal outcomes at HV centers and vice versa. Another important limitation of this study was that there essentially are no data regarding the appropriate use of ERCP. Although an ERCP may be successful technically, this does not mean that an ERCP was required. Ensuring the appropriate use of ERCP is an area in need of additional study. Furthermore, as noted earlier, a clear definition of procedure success will be required as we move forward. Specifically, it is unclear whether the use of endoscopic ultrasound access in failed ERCP is truly a procedure failure. In addition, although all studies attempted to account for variations in procedure complexity, ambiguity remains in these definitions and their accuracy has not been validated. There was significant heterogeneity in the assessment of some key outcomes (endoscopist volume and success rates and center volume and composite AE rates). This was expected given the inclusion of multinational studies and varying study protocols. This tempers the confidence level associated with some of the estimates reported in this study and the precision of these estimates may change as data from large quality registries and prospective multicenter trials become available. The limited number of studies precluded assessment of association between volumes and other outcomes such as individual adverse events (bleeding, perforation), length of hospital stay, and repeat interventions. Similarly, the a priori assessment of potential factors associated with heterogeneity was not performed with the limited number of studies. The lack of association between volumes and the risk of post-ERCP pancreatitis needs to be explored further. We also acknowledge that, ultimately, volume is a surrogate measure of technical skill and future studies are required to assess technical skills using a validated evaluation tool and assess these with hard patient outcomes (success and AEs).
Despite the limitations of volume-outcome data, these results have significant implications. Moving forward, these results suggest that there are reasonable steps that may be undertaken without markedly impacting the practice infrastructure or patient experience. As suggested previously, 33 centralizing ERCP care to 1 to 2 regional endoscopists may eliminate low-volume endoscopists and allow endoscopists to have a requisite volume to maintain skills. This will allow for an adequate cohort of endoscopists well trained in ERCP to address standard procedures and emergencies in communities and refer complex cases to tertiary care referral centers. Regionalizing ERCP practice, but not requiring that patients receive care at a few tertiary care centers, would minimize the impact (eg, driving distance) on patients but still lead to higher-volume endoscopists performing ERCP. These results also call for a critical evaluation of ERCP procedure volumes and more importantly their outcomes in relation to published quality indicators in ERCP, 32 especially among low-volume endoscopists/ centers. Finally, these results also have significant implications for the process of credentialing and privileging endoscopists performing ERCP. 34 Our systematic review showed that increasing ERCP volume (endoscopist and center) is associated with increasing procedure success. Furthermore, our results suggest that increasing endoscopist volume is associated with lower AE rates. Given these compelling findings, we propose that providers and payers consider consolidating ERCP to high-volume endoscopists and centers to improve ERCP outcomes and value.
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